Electrophysiology

The cardiac subspecialty of electrophysiology (EP) diagnoses and treats arrhythmias. This includes use of pacemakers to treat bradycardia, implantable cardioverter defibrillators (ICD) for tachycardia, heart failure and patients at risk of sudden cardiac arrest, and cardiac ablation treatments to treat heart rhythm disorders.

Johnson & Johnson MedTech launches new 2D ICE catheter
The company says the new device was designed to improve image quality, provide additional maneuverability and simplify ablation workflows for electrophysiologists.
Johnson & Johnson MedTech ordered to pay $147M for antitrust violations
The company told Cardiovascular Business it respectfully disagrees with the jury's decision and is evaluating all possible legal options going forward. The Association of Medical Device Reprocessors, meanwhile, celebrated the news.
Cardiologists are first in world to use new cooling device to terminate AFib during surgery
Patients often develop AFib during cardiac surgery, leading to longer hospital stays, additional healthcare costs and a higher risk of mortality. Cooling the oblique sinus of the patient's heart as soon as AFib starts to develop may represent a new way to stop the problem in its tracks.
World’s first leadless LBBAP procedures linked to ‘promising’ outcomes
Cardiologists are turning to leadless pacemakers more and more for cardiac pacing, but those devices have not previously been able to perform LBBAP. This new analysis includes new data on the world’s very first leadless LBBAP procedures.
AI predicts LBBB risk in TAVR patients prior to treatment
The authors tested out a variety of machine learning techniques, including large language models and more traditional algorithms. They focused on data that can be gathered prior to treatment, ensuring cardiologists know as much as possible before the procedure.

AFib before and after TAVR linked to significant risks

The new study included data on patients who presented for TAVR with preexisting AFib as well as those who developed new-onset AFib after the procedure.

Venture capital firm raises $90M, launches new AFib ablation company

According to Ajax Health CEO and industry veteran Duke Rohlen, the new company will be focused on offerings that "prioritize precision, simplicity and efficiency."

older patient with a doctor at their house

Learning more about AFib: 19 important topics for cardiologists, other heart specialists to investigate

New AFib recommendations from the American College of Cardiology and American Heart Association covered significant ground—but there is still much more to learn, experts explained.

New AFib guidelines include higher recommendations for catheter ablation, LAAO

Cardiologists, electrophysiologists, surgeons and patient representatives all worked together on the updated guidelines, which were published in both the Journal of the American College of Cardiology and Circulation.

Johnson & Johnson acquires medical device company behind new LAA technology for $400M

The deal could also include additional clinical and regulatory milestone payments in the years ahead.

Medtronic Penditure Left Atrial Appendage (LAA) Exclusion System

Medtronic debuts new FDA-cleared LAA exclusion device

Medtronic acquired the technology behind the new device back in August.

Medtronic's PulseSelect Pulse Field Ablation (PFA) System

Medtronic gains 2 key approvals for its ablation portfolio

The company had good news to share about its highly anticipated PFA offering.

AI cardiology heart artificial intelligence deep learning

The future of cardiology: 5 potentially game-changing AI studies from AHA 2023

AI was one of the biggest stories at the American Heart Association’s Scientific Sessions 2023 conference in Philadelphia. Researchers presented new data about heart attack care, voice recognition algorithms, digital stethoscopes and more.

Electrophysiology

Johnson & Johnson MedTech launches new 2D ICE catheter

Johnson & Johnson MedTech ordered to pay $147M for antitrust violations

Cardiologists are first in world to use new cooling device to terminate AFib during surgery

World’s first leadless LBBAP procedures linked to ‘promising’ outcomes

AI predicts LBBB risk in TAVR patients prior to treatment